Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CG | P48736 | 5/20 | 0.42 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.40 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.40 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.39 |
| ▸ | PI4KA | P42356 | 7/20 | 0.37 |
| ▸ | PI4K2B | Q8TCG2 | 7/20 | 0.37 |
| ▸ | PI4K2A | Q9BTU6 | 7/20 | 0.37 |
| ▸ | PI4KB | Q9UBF8 | 7/20 | 0.37 |
| ▸ | NUDT1 | P36639 | 2/20 | 0.37 |
| ▸ | XDH | P47989 | 2/20 | 0.35 |
| ▸ | LRRK2 | Q5S007 | 2/20 | 0.35 |
| ▸ | RET | P07949 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | DRD3 | P35462 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10960612 | 0.81 | — | — | |
| SCHEMBL8823861 | 0.79 | — | — | |
| SCHEMBL42313 | 0.78 | ADORA2A (0.42) | PIK3CGADORA2AADORA1ERAP1PI4KA | |
| SCHEMBL8565 | 0.75 | ADORA2A (0.58) | ADORA2AADORA1ERAP1PI4KAPI4K2B | |
| SCHEMBL953009 | 0.75 | NUDT1 (0.41) | ADORA2AADORA1ERAP1PI4KAPI4K2B | |
| SCHEMBL12620888 | 0.75 | ADORA2A (0.40) | PIK3CGADORA2AADORA1ERAP1PI4KA | |
| SCHEMBL4581404 | 0.75 | PI4KA (0.41) | PIK3CGADORA2AADORA1ERAP1PI4KA | |
| SCHEMBL159639 | 0.75 | ADORA2A (0.40) | PIK3CGADORA2AADORA1ERAP1PI4KA | |
| SCHEMBL842439 | 0.75 | ADORA2A (0.40) | PIK3CGADORA2AADORA1ERAP1PI4KA | |
| SCHEMBL160304 | 0.75 | ADORA2A (0.40) | PIK3CGADORA2AADORA1ERAP1PI4KA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4072 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12630827-B2 | Antisense oligonucleotides targeting SCN2A for the treatment of SCN1A encephalopathies | ROGCON, INC. (US) | 2026-05-19 | — | — | US | claimed |
| US-20250257360-A1 | OLIGONUCLEOTIDE INTERFERENCE TREATMENTS OF PROSTATE CANCER | UNIV OKLAHOMA (US) | 2025-08-14 | — | — | US | claimed |
| CN-113151261-B | Antisense oligonucleotides as inhibitors of TGF-R signaling | 神经视觉医药有限公司 | 2025-06-17 | — | — | CN | claimed |
| US-20250179503-A1 | METHODS OF USING OLIGOMERIC COMPOUNDS TO TREAT SCN2A-RELATED DISORDERS | PRAXIS PREC MEDICINES INC (US) | 2025-06-05 | — | — | US | claimed |
| WO-2025110816-A1 | COMBINATION THERAPY OF ANTICANCER TREATMENT WITH TOLL-LIKE RECEPTOR 7 OR 8 AGONIST HAVING ACTIVE SITE TEMPORARILY INACTIVATED FOR CANCER TREATMENT | 프로지니어 주식회사 | 2025-05-30 | — | — | WO | claimed |
| US-20250146073-A1 | METHODS FOR THE TREATMENT OF SCN2A-RELATED DISORDERS | PRAXIS PREC MEDICINES INC (US) | 2025-05-08 | — | — | US | claimed |
| EP-4504945-A2 | OLIGONUCLEOTIDE INTERFERENCE TREATMENTS OF PROSTATE CANCER | The Board of Regents of the University of Oklahoma (US) | 2025-02-12 | — | — | EP | claimed |
| EP-4506456-A1 | NOVEL OXO-RNA COMPOSITIONS AND THE RELATED APPLICATIONS THEREOF | Lin, Shi-Lung (US) | 2025-02-12 | — | — | EP | claimed |
| US-12215343-B2 | Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-02-04 | — | — | US | claimed |
| US-20250019709-A1 | NOVEL OXO-RNA COMPOSITIONS AND THE RELATED APPLICATIONS THEREOF | LIN SHI LUNG (US) | 2025-01-16 | — | — | US | claimed |
| US-6548252-B1 | Electrochemically analyzing samples from selected areas of the body of a living organism for elevated free levels of nucleotide excision products resulting from DNA or RNA damage | ESA, INC. | 2003-04-15 | — | — | US | claimed |
| US-20030036072-A1 | Detection of preferential nucleotide sequences in sample; obtain nucleic acids, incubate with probes, detect signal from sample | DEFENCE, SECRETARY OF STATE FOR, THE (GB) | 2003-02-20 | — | — | US | claimed |
| US-6187551-B1 | HYBRIDOMA CULTURE PRODUCT | CYTOCHEM, INC. | 2001-02-13 | — | — | US | claimed |
| EP-0898575-A2 | A COMBINATORIAL PROTECTING GROUP STRATEGY FOR MULTIFUNCTIONAL MOLECULES | KÖSTER, Hubert (US) | 1999-03-03 | — | — | EP | claimed |
| EP-0706581-A4 | DNA PROFILES AS AN INDICATOR OF CELLULAR REDOX POTENTIAL AND CANCER RISK | PACIFIC NORTHWEST RESEARCH FOU (US) | 1999-02-10 | — | — | EP | claimed |
| WO-1997041139-A2 | A COMBINATORIAL PROTECTING GROUP STRATEGY FOR MULTIFUNCTIONAL MOLECULES | KOESTER HUBERT (US) | 1997-11-06 | — | — | WO | claimed |
| US-5665553-A | Methods for determining and modulating cellular redox potential and genotoxic states | PACIFIC NORTHWEST RESEARCH FOUNDATION (US) | 1997-09-09 | — | — | US | claimed |
| US-5601981-A | ASSAYING DNA FROM TEST SPECIMEN FOR CONCENTRATION OF RING-OPENED AND HYDROXYL DERIVATIVES, COMPARING, WHEREIN REDUCTIVE CELLULAR REDOX POTENTIAL EXISTS WHEN FORMATION OF RING-OPENED OVER HYDROXYL DERIVATIVES IS FAVORED | PACIFIC NORTHWEST RESEARCH FOUNDATION (US) | 1997-02-11 | — | — | US | claimed |
| EP-0706581-A1 | DNA PROFILES AS AN INDICATOR OF CELLULAR REDOX POTENTIAL AND CANCER RISK | PACIFIC NORTHWEST RESEARCH FOUNDATION (US) | 1996-04-17 | — | — | EP | claimed |
| WO-1994025626-A1 | DNA PROFILES AS AN INDICATOR OF CELLULAR REDOX POTENTIAL AND CANCER RISK | PACIFIC NORTHWEST RESEARCH FOUNDATION (US) | 1994-11-10 | — | — | WO | claimed |